Regulations

Lilly invests heavily in UK

Lilly invests heavily in UK

US pharmaceutical major Eli Lilly has earmarked a hefty £220
million (€304 million) investment over the next four years in its
UK facilities, representing the largest investment by the firm in
any European country.

FDA panel mulls cGMP issues

FDA panel mulls cGMP issues

As this edition of In-pharmatechnologist.com goes online, the US
Food and Drug Administration is convening the inaugural meeting of
its Advisory Committee for Pharmaceutical Science's Manufacturing
Subcommittee.

Meeting GMP standards

Meeting GMP standards

Invensys APV, a supplier of process equipment to the pharmaceutical
industry, will demonstrate its new technologies at the upcoming
Achema 2003 exhibition in Frankfurt, Germany.

HQ for Euro biotech

HQ for Euro biotech

The European Federation of Biotechnology (EFB) is setting up a
trade office in Aarhus, Denmark for its activities in innovation
and functional genomics, reports Biotech Denmark on its website.

UK biotech collaboration

UK biotech collaboration

Two British firms, De Novo Pharmaceuticals and Peakdale Molecular,
are to enter into a joint collaboration to exploit their respective
skills in molecular design and chemistry synthesis, writes market
analysts Datamonitor this week.

Biogen digs into Europe

Biogen digs into Europe

Biotechnology company Biogen this week celebrated its 25th
anniversary by breaking the ground on a large-scale manufacturing
facility in Hillerød, Denmark, marking the company's first
development phase for the region and a greater...

Pharma boom for Denmark

Pharma boom for Denmark

Data published by the Danish Association of the Pharmaceutical
Industry (LIF) reveals a boom in pharmaceutical exports in 2002.
Sales totalled DK30.3 billion (€4.3 billion), an increase of
approximately DK2 billion (€268 million)...

Xenogen in Japan

Xenogen in Japan

SC Biosciences is to be the exclusive distributor of sensitive
tools for drug discovery with the announcement this week that it
will distribute in vivo imaging technology in Japan for US company
Xenogen corporation.

Softly, softly...

Softly, softly...

German pharmaceutical company Boehringer Ingelheim has signed a
long-term agreement with software company MDL Information Systems
to use its software technology for managing and deploying chemical
information systems.

Fund setback for world leader

Fund setback for world leader

Applied Biosystems group, the world's number one maker of
gene-analysing equipment, warned on Tuesday that it would report
lower-than-expected fiscal third-quarter revenue and earnings due
to deteriorating business conditions.

Asia-Pacfic focus

Asia-Pacfic focus

Singapore is the location for the first 'Drug Discovery Technology'
event organised by IBC Life Sciences in the Asia-Pacific region.

Life science boost

Life science boost

Strong sales from its life science unit helped US biotechnology
company Enzo Biochem, that specialises in gene identification
technologies, post total revenues of $13.1 million, compared with
$11.8 million in the corresponding year...

Follow us

Product Innovations

Multiple Sclerosis Analytical Report

Multiple Sclerosis Analytical Report

More than 2.3 million people are living with MS worldwide. Although there is no cure, new research and innovative treatments are continuously emerging....